A Matched Case-Case-Control Study of the Impact of Clinical Outcomes and Risk Factors of Patients with IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae in Japan-Reference-Cited by-同舟云学术

A Matched Case-Case-Control Study of the Impact of Clinical Outcomes and Risk Factors of Patients with IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae in Japan

Published:2021-02-17 Issue:3 Volume:65 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Saito Sho¹²³^ORCID,Hayakawa Kayoko¹²,Tsuzuki Shinya²⁴,Ishikane Masahiro¹²,Nagashima Maki¹,Mezaki Kazuhisa⁵,Sugiki Yuko⁶,Tajima Taichi²,Matsunaga Nobuaki²,Ide Satoshi¹³,Kinoshita Noriko¹²³,Kusama Yoshiki²³,Fujitomo Yumiko²,Nakamoto Takato¹,Toda Yuta¹,Kaku Mitsuo⁷,Kodama Eiichi N.⁸,Ohmagari Norio¹²³

Affiliation:

1. Disease Control and Prevention Center, National Centre for Global Health and Medicine, Tokyo, Japan

2. AMR Clinical Reference Center, National Centre for Global Health and Medicine, Tokyo, Japan

3. Department of Emerging and Reemerging Infectious Diseases, Tohoku University School of Medicine, Sendai, Miyagi, Japan

4. Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium

5. Microbiology Laboratory, National Center for Global Health and Medicine, Tokyo, Japan

6. Infection Control and Prevention, National Center for Global Health and Medicine, Tokyo, Japan

7. Department of Infection Control and Laboratory Diagnostics, Tohoku University School of Medicine, Sendai, Miyagi, Japan

8. Division of Infectious Diseases, School of Medicine, International Research Institute of Disaster Science, and Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan

Abstract

IMP-type carbapenemase, found in various Gram-negative bacteria, has been increasingly detected worldwide. We aimed to study the outcomes and risk factors for acquisition of IMP-type carbapenemase-producing carbapenem-resistant Enterobacteriaceae (IMP-CRE), as this has not been evaluated in detail.

Funder

International Health Research from the Ministry of Health, Labor and Welfare of Japan

MEXT | Japan Society for the Promotion of Science

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01483-20

Reference33 articles.

1. Review on Antimicrobial Resistance. 2014. Review on antimicrobial resistance: tackling a crisis for the health and wealth of nations. Review on Antimicrobial Resistance, London, United Kingdom. https://amr-review.org/sites/default/files/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf.

2. World Health Organization. 2017. WHO publishes list of bacteria for which new antibiotics are urgently needed. https://www.who.int/news-room/detail/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed. Accessed 20 June 2019.

3. In-vivo loss of carbapenem resistance by extensively drug-resistant Klebsiella pneumoniae during treatment via porin expression modification

4. Characterization of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae from a healthcare region in Hong Kong

5. Carbapenemase genes and genetic platforms in Gram-negative bacilli: Enterobacteriaceae, Pseudomonas and Acinetobacter species

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Factors for Carbapenemase-Producing Enterobacterales Colonization upon Admission to Tertiary Hospital Hematology Units: A Retrospective Case-control Study;Journal of Korean Academy of Fundamentals of Nursing;2024-05-31

2. A case–control study of the clinical and economic impact of infections caused by Carbapenemase-producing Enterobacterales (CPE);Infection;2024-05-03

3. Burden of Antimicrobial Resistance in Japan: A Systematic Literature Review and Meta-Analysis;Infectious Diseases and Therapy;2024-04-25

4. Clinical and microbiological characteristics of bacteremia caused by carbapenemase-producing <i>Enterobacterales</i> in Minami Ibaraki area, Japan;Journal of Microorganism Control;2024

5. Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales;Infectious Diseases and Therapy;2023-02-25